Cerebrovascular Diseases
Original Paper
Analysis of 16,922 Patients with Acute Ischemic Stroke and Transient Ischemic Attack in JapanA Hospital-Based Prospective Registration Study Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, Osaka, Japan
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: September 17, 2003
Accepted: December 10, 2003
Published online: December 07, 2004
Issue release date: July 2004
Number of Print Pages: 10
Number of Figures: 2
Number of Tables: 3
ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)
For additional information: https://www.karger.com/CED
Abstract
Objective: The purpose of the present study was to clarify the present status of stroke medicine in Japan using a hospital-based, prospective registration study of 156 hospitals from all over Japan. Methods: Consecutive patients with acute ischemic stroke and transient ischemic attack (TIA) who presented to hospital within 7 days of onset from May 1999 to April 2000 were enrolled in this study. A common protocol was applied in every participating hospital. Results: A total of 16,922 patients (TIA, 6.4%) with a mean age of 70.6 ± 11.5 years (median 71 years, range 18–107 years) were enrolled in the study. Lacunar stroke was the most frequent stroke subtype (38.8%), followed by atherothrombotic (33.3%), cardioembolic (21.8%) and other stroke (6.1%). NIHstroke scale score on admission was 8.0 ± 7.9 (median 5; 25th to 75th percentile, 2–11). 36.8% arrived at hospital within 3 h of symptom onset, and 49.5% within 6 h. The ambulance was used for 70.2% of patients arriving within 3 h after onset, but in only 29.9% of patients visiting the hospital later than 3 h after onset (p < 0.0001). 60.8% displayed good outcome (modified Rankin Scale score of 0–2 at discharge), while 32.3% displayed poor outcome (score 3–5), and mortality rate was 6.9%. Conclusions: More than half of the acute stroke patients arrived at hospital later than 6 h after onset. Establishment of ideal emergency systems is needed for better management of stroke and for improvement of patient outcome, in particular, in the future after approval of intravenous recombinant tissue plasminogen activator for acute ischemic stroke by the Japanese government.
© 2004 S. Karger AG, Basel
Related Articles:
References
- Sarti C, Rastenyte DR, Cepaitis Z, Tuomilehto J: International trends in mortality from stroke, 1968 to 1994. Stroke 2000;31:1588–1601.
-
Ministry of Health, Labour and Welfare: Social and Economic Changes Surrounding Individuals. Annual Report on Health, Labour and Welfare 2000–2001. Health, Labour and Welfare Administration for Providing Life-Long Support to Self-Sufficiency of the People. Tokyo, Gyosei Corporation, 2002, pp 4–88.
- Morikawa Y, Nakagawa H, Naruse Y, Nishijo M, Miura K, Tabata M, Hirokawa W, Kagamimori S, Honda M, Yoshita K, Hayashi K: Trends in stroke incidence and acute case fatality in a Japanese rural area. The Oyabe study. Stroke 2000;31:1583–1587.
- Kodama K: Stroke trends in Japan. Ann Epidemiol 1993;3:524–528.
-
Ministry of Health, Labour and Welfare: Social and Economic Changes Surrounding Individuals. Annual Report on Health, Labour and Welfare 2000–2001. Health, Labour and Welfare Administration for Providing Life-Long Support to Self-Sufficiency of the People. Tokyo, Gyosei Corporation 2002, pp 136–150.
-
Statistics and Information Department, Minister’s Secretariat, Ministry of Health, Labour and Welfare: National Medical Care Expenditure by Age Group, Service Type and per capita, in Japan. National Medical Care Expenses (in Japanese). Tokyo, Jino, 2002, pp 72–73.
- Special Report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21:637–675.
- Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J: Improved reliability of the NIH Stroke Scale using video training. NINDS tPA Stroke Study Group. Stroke 1994;25:2220–2226.
- van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
- Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population. The Hisayama study. Stroke 2000;31:2616–2622.
- Bogousslavsky J, Van Melle G, Regli F: The Lausanne stroke registry: Analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083–1092.
- Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO: Ischemic stroke subtype. A population-based study of incidence and risk factors. Stroke 1999;30:2513–2516.
-
Kolominisky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtype: A population-based study. Stroke 2001;31:2735–2740.
- Friday G, Lai SM, Alter M, Sobel E, LaRue L, Gil-Peralta A, McCoy RL, Levitt LP, Isack T: Stroke in the Lehigh Valley: Racial/ethnic differences. Neurology 1989;39:1165–1168.
- Caplan LR, Gorelick PB, Hier DB: Race, sex and occlusive cerebrovascular disease: A review. Stroke 1986;17:648–655.
-
Arima H, Kiyohara Y, Fujishima M: The changing pattern of hypertension in a long-term follow-up survey of a Japanese community: the Hisayama Study (in Japanese). Nippon Rinsho 2000;607–610.
- Fisher CM: Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979;36:65–73.
- National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
- Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerichi M, for the ECASS Study Group: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–1025.
-
Wardlaw JM: Overview of Cochrane thrombolysis meta-analysis. Neurology 2001;57(5 suppl 2):S69–S76.
- Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM: Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001;56:1015–1020.
- Chiu D, Krieger D, Villar-Cordova C, Kasner S, Mongenstern L, Bratina P, Yatsu F, Grotta J: Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18–22.
- Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W: Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 1996;27:1711–1718.
- Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL: Stroke unit treatment improve long-term quality of life. A randomized controlled trial. Stroke 1998;29:895–899.
- Ronning OM, Guldvog B: Stroke unit versus general ward. 1. Twelve- and eighteen-month survival. A randomized controlled trial. Stroke 1998;29:58–62.
- Yip PK, Jeng JS, Lee TK, Chang YC, Haung ZS, Ng SK, Chen RC: Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke 1997;28:2507–2512.
- Brutto OHD, Mosquera A, Sanchez X, Santos J, Noboa CA: Stroke subtype Hispanics living from Guayaquil, Ecuador. Results from the Luis Vernaza Hospital Stroke Registry. Stroke 1993;24:1833–1836.
- Lee BI, Nam HS, Heo JH, Kim DI: Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis 2001;12:145–151.
- Foulkes MA, Wolf PA, Price TR, Mohn JP, Hier DB: The stroke data bank: design, methods, and baseline characteristics. Stroke 1988;19:547–554.
- Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D’Agostino RB: Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760–1764.
Article / Publication Details
Received: September 17, 2003
Accepted: December 10, 2003
Published online: December 07, 2004
Issue release date: July 2004
Number of Print Pages: 10
Number of Figures: 2
Number of Tables: 3
ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)
For additional information: https://www.karger.com/CED
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission